Concordis
Business Services · Washington, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1500 Westlake Ave N Ste 212, Seattle, Wa...Phone Number
(206) 347-8511Website
www.concordis.netRevenue
$14.5 MillionIndustry
About Concordis
Concordis Org Chart
Is Concordis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Concordis recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Concordis launches new products
Funding: Get notified immidiatlly once Concordis has new funding data
Check out if Concordis is spiking on competitors!
Concordis, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Concordis had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Concordis
Check if Concordis has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Concordis as Masked Content
Find 3 more new buyers
Compare Similar Companies to Concordis
Compare insights from companies similar to Concordis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Concordis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Concordis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Concordis.
Concordis financials insights
Gather financial insights about Concordis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$2M
Concordis Tech Stack
A closer look at the technologies used by Concordis
Concordis News & Media
Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy
- Initiation of Phase 3 IMPACT DUCHENNE placebo-controlled, randomized, double-blind trial as part of Solid’s integrated, multi-trial development program designed to support registration and global regulatory authorizations for SGT-003 -Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy
- Orphan drug designation from the European Commission underscores Solid’s commitment to advance SGT-003 through a global development effort for individuals living with Duchenne muscular dystrophy -Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
- Duchenne (SGT-003): Positive interim Phase 1/2 INSPIRE DUCHENNE data reported at the 2026 MDA Annual Meeting continued to suggest differentiated clinical, safety and tolerability profiles; SGT-003 has been generally well tolerated in the 41 participants dosed as of March 18, 2026 -Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
- 40 participants have been dosed with SGT-003 in the INSPIRE DUCHENNE trial to date -
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Concordis
Concordis LLC specializes in business and technology staffing and consulting services. The company aims to connect clients with the right talent and solutions to meet their needs. Their services are designed for businesses seeking expertise in technology and staffing. Concordis LLC is committed to optimizing client experiences through effective sta... Read More